Zydus to Initiate Clinical Trials Evaluating ZyCoV-D Vaccine Against COVID-19 in July 2020

Shots:

• Zydus’ ZyCoV-D has completed the preclinical studies and has received DCGI approval to initiate P-I/II human clinical trials in India. In its preclinical study, the vaccine demonstrated that it is capable to neutralize the wild type virus in the virus neutralization assay
• In its toxicology studies, the vaccine is found to be safe, well-tolerated and immunogenic
• Zydus has manufactured clinical GMP batches of the vaccine with the expected initiation of clinical trials in Jul’2020 across multiple sites in India in over 1000 subjects. Additionally, the company will ramp up the production capacities of ZyCoV-D at multiple sites to meet the global demand

Click here to read full press release/ article | Ref: Zydus | Image: Arab News